Terms: = Bone cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864
73 results:
1. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
[No Abstract] [Full Text] [Related]
2. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of cancer.
Wang Y; Wang C; Liu T; Qi H; Chen S; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
J Med Chem; 2024 Jan; 67(1):420-432. PubMed ID: 38146659
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
Sci Rep; 2023 Oct; 13(1):18546. PubMed ID: 37899376
[TBL] [Abstract] [Full Text] [Related]
5. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
6. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
7. WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Embaby A; Kutzera J; Geenen JJ; Pluim D; Hofland I; Sanders J; Lopez-Yurda M; Beijnen JH; Huitema ADR; Witteveen PO; Steeghs N; van Haaften G; van Vugt MATM; de Ridder J; Opdam FL
Gynecol Oncol; 2023 Jul; 174():239-246. PubMed ID: 37236033
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Targeted Next-Generation Panel Sequencing Reveals
Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
[TBL] [Abstract] [Full Text] [Related]
9. Deep learning-based detection of patients with bone metastasis from Japanese radiology reports.
Doi K; Takegawa H; Yui M; Anetai Y; Koike Y; Nakamura S; Tanigawa N; Koziumi M; Nishio T
Jpn J Radiol; 2023 Aug; 41(8):900-908. PubMed ID: 36988827
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
[TBL] [Abstract] [Full Text] [Related]
11. Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review.
Schutte T; Embaby A; Steeghs N; van der Mierden S; van Driel W; Rijlaarsdam M; Huitema A; Opdam F
Cancer Treat Rev; 2023 Apr; 115():102531. PubMed ID: 36893690
[TBL] [Abstract] [Full Text] [Related]
12. Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.
Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;
Am J Hematol; 2023 Mar; 98(3):381-387. PubMed ID: 36588408
[TBL] [Abstract] [Full Text] [Related]
13. Fabrication of Multifunctional Drug Loaded Magnetic Phase Supported Calcium Phosphate Nanoparticle for Local Hyperthermia Combined Drug Delivery and Antibacterial Activity.
Duraisamy K; Gangadharan A; Martirosyan KS; Sahu NK; Manogaran P; Easwaradas Kreedapathy G
ACS Appl Bio Mater; 2023 Jan; 6(1):104-116. PubMed ID: 36511628
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.
Hsu JY; Seligson ND; Hays JL; Miles WO; Chen JL
JCO Precis Oncol; 2022 Feb; 6():e2100211. PubMed ID: 35108033
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical and Cytogenetical Characteristics in Acute Myeloid Leukemia with Myelodysplasia-Related Changes].
Ma JL; Zhou AQ; Gu SY; Chen BA; Ge Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1757-1762. PubMed ID: 34893106
[TBL] [Abstract] [Full Text] [Related]
16. bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
Jann JC; Mossner M; Riabov V; Altrock E; Schmitt N; Flach J; Xu Q; Nowak V; Obländer J; Palme I; Weimer N; Streuer A; Jawhar A; Darwich A; Jawhar M; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
Nat Commun; 2021 Oct; 12(1):6170. PubMed ID: 34697318
[TBL] [Abstract] [Full Text] [Related]
17. Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma.
Zheng S; Liu Y; Sun H; Jia J; Wu T; Ding R; Cheng X
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34474553
[TBL] [Abstract] [Full Text] [Related]
18. A deep learning-machine learning fusion approach for the classification of benign, malignant, and intermediate bone tumors.
Liu R; Pan D; Xu Y; Zeng H; He Z; Lin J; Zeng W; Wu Z; Luo Z; Qin G; Chen W
Eur Radiol; 2022 Feb; 32(2):1371-1383. PubMed ID: 34432121
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic performance of tomosynthesis for evaluation of bone tumors and tumor-like lesions: a comparison with radiography.
Park S; Lee IS; Song YS; Bae JH; Kim JI; Kim CW
Acta Radiol; 2022 Aug; 63(8):1086-1092. PubMed ID: 34260321
[TBL] [Abstract] [Full Text] [Related]
20. MYC amplifications are common events in childhood osteosarcoma.
De Noon S; Ijaz J; Coorens TH; Amary F; Ye H; Strobl A; Lyskjaer I; Flanagan AM; Behjati S
J Pathol Clin Res; 2021 Sep; 7(5):425-431. PubMed ID: 33969640
[TBL] [Abstract] [Full Text] [Related]
[Next]
